163 related articles for article (PubMed ID: 27008430)
41. [Combination of external beam radiotherapy and 252Cf neutron intracavitary brachytherapy for cervical cancer].
Shan JL; Lei X; Wang D; Wang G; Li L; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):223-6. PubMed ID: 15924665
[TBL] [Abstract][Full Text] [Related]
42. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
43. Radical radiotherapy with high-dose-rate brachytherapy for uterine cervix cancer long-term results.
Khor TH; Tuan JK; Hee SW; Tham IW
Australas Radiol; 2007 Dec; 51(6):570-7. PubMed ID: 17958695
[TBL] [Abstract][Full Text] [Related]
44. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
[TBL] [Abstract][Full Text] [Related]
45. Does the entire uterus need to be treated in cancer of the cervix? Role of adaptive brachytherapy.
Anker CJ; Cachoeira CV; Boucher KM; Rankin J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):704-12. PubMed ID: 19473779
[TBL] [Abstract][Full Text] [Related]
46. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY
Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610
[TBL] [Abstract][Full Text] [Related]
47. Definitive Chemoradiotherapy in Elderly Cervical Cancer Patients: A Multiinstitutional Analysis.
Guler OC; Sari SY; Birgi SD; Gultekin M; Yildiz F; Onal C
Int J Gynecol Cancer; 2017 Sep; 27(7):1446-1454. PubMed ID: 28604459
[TBL] [Abstract][Full Text] [Related]
48. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
49. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
50. Overall survival in patients with FIGO stage IVA cervical cancer.
Schiff JP; Mintz R; Cohen AC; Huang Y; Thaker P; Massad LS; Powell M; Mutch D; Schwarz JK; Markovina ST; Grigsby PW
Gynecol Oncol; 2022 Aug; 166(2):292-299. PubMed ID: 35691754
[TBL] [Abstract][Full Text] [Related]
51. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
52. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?
Rockall AG; Ghosh S; Alexander-Sefre F; Babar S; Younis MT; Naz S; Jacobs IJ; Reznek RH
Gynecol Oncol; 2006 May; 101(2):244-9. PubMed ID: 16310245
[TBL] [Abstract][Full Text] [Related]
53. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
[TBL] [Abstract][Full Text] [Related]
54. Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients.
Cho Y; Kim KH; Yoon HI; Kim GE; Kim YB
Ann Oncol; 2016 Nov; 27(11):2067-2074. PubMed ID: 27502717
[TBL] [Abstract][Full Text] [Related]
55. Revisiting the role of computerized tomographic scan and cystoscopy for detecting bladder invasion in the revised FIGO staging system for carcinoma of the uterine cervix.
Sharma DN; Thulkar S; Goyal S; Shukla NK; Kumar S; Rath GK; Julka PK; Saini G; Bahl A
Int J Gynecol Cancer; 2010 Apr; 20(3):368-72. PubMed ID: 20375799
[TBL] [Abstract][Full Text] [Related]
56. The feasibility of reduced field-of-view diffusion-weighted imaging in evaluating bladder invasion of uterine cervical cancer.
Takeuchi M; Matsuzaki K; Harada M
Br J Radiol; 2022 Jan; 95(1129):20210692. PubMed ID: 34705531
[TBL] [Abstract][Full Text] [Related]
57. Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion.
Shiba S; Wakatsuki M; Kato S; Ohno T; Okonogi N; Karasawa K; Kiyohara H; Tsujii H; Nakano T; Kamada T; Shozu M;
J Radiat Res; 2016 Nov; 57(6):684-690. PubMed ID: 27422932
[TBL] [Abstract][Full Text] [Related]
58. Endoscopic assessment of radiological stage IVA cervical cancer: A bivariate meta-analysis supporting an evidence-based staging algorithm proposal.
Sapienza LG; Thomas JJ; Showalter TN; Echeverria AE; Ludwig MS; Chen AC; Jo E; Calsavara VF; Hilsenbeck SG; Jhingran A; Frumovitz MM; Baiocchi G
Gynecol Oncol; 2022 Jun; 165(3):642-649. PubMed ID: 35410732
[TBL] [Abstract][Full Text] [Related]
59. Feasibility study of Californium-252 for the therapy of stage IV cervical cancer.
Maruyama Y; Van Nagell JR; Yoneda J; Donaldson E; Gallion H; Patel P; Kryscio RJ
Cancer; 1988 Jun; 61(12):2448-52. PubMed ID: 3130179
[TBL] [Abstract][Full Text] [Related]
60. Carcinoma of the cervical stump.
Petersen LK; Mamsen A; Jakobsen A
Gynecol Oncol; 1992 Aug; 46(2):199-202. PubMed ID: 1500023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
